Patent Grant
11896799
There are many applications in academic, industrial, and medical fields, as well as others, that benefit from devices and methods that are capable of accurately and controllably delivering fluids, including liquids and gases that have a beneficial effect when administered in known and controlled quantities. Such devices and methods are particularly useful in the medical field where treatments for many patients include the administration of a known amount of a substance at predetermined intervals.
Insulin-injecting pumps have been developed for the administration of insulin for those suffering from both type I and II diabetes. Continuous subcutaneous insulin injection and/or infusion therapy with portable infusion device has been adapted for the treatment of diabetes. Such therapy may include the regular and/or continuous injection or infusion of insulin into the skin of a person suffering from diabetes and offer an alternative to multiple daily injections of insulin by an insulin syringe or an insulin pen. Such pumps can be ambulatory/portable infusion pumps that are worn by the user that may use replaceable cartridges. Examples of such pumps and various features that can be associated with such pumps include those disclosed in U.S. patent application Ser. No. 13/557,163, U.S. patent application Ser. No. 12/714,299, U.S. patent application Ser. No. 12/538,018, U.S. Provisional Patent Application No. 61/655,883, U.S. Provisional Patent Application No. 61/656,967 and U.S. Pat. No. 8,287,495, each of which is incorporated herein by reference.
There are, however, some drawbacks associated with the use of subcutaneous injection syringes and/or some currently available infusion pumps for the delivery of insulin and other medicaments. Some commercially available pumps may have an interchangeable infusion cartridge containing insulin and/or other medicaments. The correct attachment of this interchangeable infusion cartridge is important for the proper delivery of medicament. For instance, the cartridge may inadvertently become detached or may not be attached to the pump, resulting in possible inaccuracies in treatment and other issues.
Therefore, there is a need for a system and a method for detecting the presence or absence of the infusion cartridge in the infusion pump.
Disclosed herein are systems and methods for detecting the presence of an interchangeable infusion cartridge in an infusion pump and particularly in a portable or ambulatory infusion pump. In some embodiments, the method may include installing an infusion cartridge in an infusion pump, initiating an infusion cartridge loading sequence, recording loading pulse width modulation (PWM) commands applied to an infusion pump motor, setting a value of threshold PWM commands, comparing values of operational PWM commands applied during pumping operations to the value of the threshold PWM commands, and generating a missing cartridge indication whenever the value of an operational PWM command drops below the value of the threshold PWM commands by a predetermined amount.
In some embodiments an infusion system is provided. The infusion system may be configured for detecting a presence or absence of an infusion cartridge. The infusion system may include an infusion cartridge and an infusion pump. The infusion cartridge may include a delivery mechanism for effectuating delivery of fluid having an axial bore, a spool which may be disposed within the axial bore and axially translatable within the axial bore, and a drug delivery reservoir for storing fluid. The infusion pump may include a drive mechanism and a processor. The processor may be coupled to a memory configured for receiving input data from the memory and using input data for generating operational parameters for the infusion system. Programming may be stored in the memory for execution by a processor to control a closed-loop motor control algorithm. The closed-loop motor control algorithm may be configured for generating PWM commands that operate a motor of the drive mechanism, and to indicate an absence of the infusion cartridge if the value of the operational PWM command falls below the predetermined value the threshold PWM commands.
Certain embodiments are described further in the following description, examples, claims, and drawings. These features of embodiments will become more apparent from the following detailed description when taken in conjunction with the accompanying exemplary drawings.
Provided herein are systems, devices and methods for continuous or semi-continuous monitoring of the absence or presence of an interchangeable infusion cartridge in an infusion pump, and particularly in a portable or ambulatory infusion pump utilizing a replaceable cartridge containing insulin and/or other medicaments for the treatment of diabetes. Some embodiments may include advances in the internal components, the control circuitry, and improvements in a user interface of the systems and devices. The advances may allow for a safer and more accurate delivery of medicament to a patient than is currently attainable today from other devices, systems, and methods. Although embodiments described herein may be discussed in the context of the controlled delivery of insulin, delivery of other medicaments, including, for example, glucagon, pramlintide, etc., as well as other applications are also contemplated. Device and method embodiments discussed herein may be used for pain medication, chemotherapy, iron chelation, immunoglobulin treatment, dextrose or saline IV delivery, or any other suitable indication or application. Non-medical applications are also contemplated.
It should be noted that labels associated with operations described herein do not necessarily represent an order in a sequence; rather, they are used only to uniquely identify each operation. The words “loaded”, “written”, and “programmed” are used interchangeably in this document when they refer to a processor or a memory device. The terms “pump” and “infusion pump” may be used interchangeably throughout the document as may be the terms “fluid” and “liquid medicament.” In addition, the terms “pulse width modulation (PWM) commands” and “PWM commands” interchangeably represent a series of electrical pulses provided to power an electric motor of the infusion pump. A value of PWM commands generally represents a duty cycle of the series of pulses during a command sequence. For example, if the PWM is 100% with an input voltage of 3.0 volts, the output will be 3.0 volts. If the PWM command is 50%, the output voltage of the same 3.0 volt input would be 1.5 volts.
The processor 42 can function to control the overall operation of the pump. Processor 42 may communicate with and/or otherwise control the drive mechanism, output/display, memory, transmitter/receiver, and the like. Processor 42 of the infusion pump may communicate with a processor of another device, such as a continuous glucose monitor, a remote controller/commander, etc. Processor 42 may include programming that can control the infusion of insulin or other medicament from the cartridge, the data to be displayed by the display, the data to be transmitted via the transmitter, etc. Part of the programming may be configured to control an electric motor 170 depicted in
According to an embodiment, a motor control program may be stored in the memory 30 for retrieval by the processor 42 to operate a closed-loop motor control algorithm. The closed-loop motor control algorithm may be configured for generating PWM commands. The PWM commands may be, e.g., a series of uniform amplitude voltage pulses that are used to measure the command input into the motor. The PWM commands may be coupled to the electric motor 170 to power a drive mechanism 48. An embodiment of the motor control algorithm may be a velocity loop algorithm. Such a velocity loop algorithm can be a proportional-integral-derivative (PID) loop in which motor velocity is the controlled output. A value of the PWM commands may be proportional to a load on the electric motor 170. The load may differ greatly, depending on the presence or absence of an infusion cartridge 16. In the case where the infusion cartridge 16 is absent, a smaller load may indicate this absence.
The processor 42 may also include additional programming to allow the processor 42 to learn user preferences and/or user characteristics and/or user history data. For instance, to implement changes in use, suggestions based on detected trends, such as, weight gain or loss, and may include programming allowing the device to generate reports, such as user history, compliance, trending, and/or other such data. Additionally, infusion pump embodiments of the disclosure may include a “power off” or “suspend” function for suspending one or more functions of the device, such as, suspending a delivery protocol, and/or for powering off the device or the delivery mechanism thereof. For some embodiments, two or more processors may be used for controller functions of the infusion pumps, including a high power processor and a low power processor used to maintain programming and pumping functions in low power mode in order to, e.g., save battery life.
Housing 26 of the infusion pump 12 may be functionally associated with an interchangeable and a removable glucose meter 20 and/or infusion cartridge 16. The infusion cartridge 16 may have an outlet port 54 that may be connected to an infusion set (not shown) via an infusion set connector 18 (as shown in
Referring now to
Method 200 may start the PWM calibration phase 210 at operation S211. In operation S211, an infusion cartridge may be installed in an infusion pump such as, for example, as described above. In operation S212, an infusion cartridge loading sequence may be initiated. During the loading sequence an electric infusion pump motor, propelling a drive mechanism, may engage a fluid delivery mechanism within the infusion cartridge. The engaged fluid delivery mechanism may represent a specific load on the infusion pump motor. In operation S213, PWM commands applied on the infusion pump motor during the loading sequence may be recorded into memory. For example, the PWM commands may have a percent/value ranging from 20% to 80%. In operation S214, an average value of the recorded PWM commands may be calculated. In operation S215, a value threshold of the PWM commands may be set to be the average value of the recorded PWM commands may be, for example, 52%. Because the PWM configuration procedure 210 can be done each time a cartridge is loaded, the threshold can be set at an appropriate value for each specific cartridge. This is advantageous because the load that each cartridge imparts on the motor can vary greatly.
After a threshold value has been established for a particular cartridge, a pumping phase 220 can be begun. In operations S221 and S222, during the pump phase 220, applied values of the operational PWM commands may be recorded and the average values of those operational PWM commands may be calculated. The PWM commands can be recorded and averaged for the duration of each distinct motor move. In operations S223 and S224, during each subsequent motor move in a pumping cycle, the average value of the operational PWM commands may be compared to the threshold value of the PWM commands. For example, the average value may be somewhere between 40% and 90%.
If an average value of the operational PWM commands is smaller, by a predetermined amount, than the value of the threshold PWM commands, a missing infusion cartridge indication/warning may be generated in operation 225, and the pumping may be halted. In some embodiments, the average value of more than one motor move must deviate from the threshold to generate an alarm. In one embodiment, the alarm is generated if two motor moves in a row generate an average PWM value greater that deviate from the threshold by the predetermined amount. In certain embodiments, the number of motor move values that must cross the threshold to generate an alarm can be adjusted to vary the sensitivity of the alarm. If an average value of the operational PWM commands is larger, by the predetermined value, than the value of threshold PWM commands, the pumping may continue in operation S221. In one example, the predetermined amount may be 10%. Thus, in the example in which the threshold value was 52%, of the average value of the operational commands is below 42%, the alarm is generated.
The predetermined value may be selected and set differently based on a selected pumping speed. For example, for a low pumping speed the predetermined value may be in the range of 20%-40% of the value of the threshold PWM command, for a high pumping speed the predetermined value may be in the range of 40%-60% of the value of the threshold PWM command. In one embodiment, this loop 220 can be conducted continuously in order to indicate that a cartridge is absent as soon as possible when a cartridge is dislodged or removed.
The constrained variable volume 122 of the delivery mechanism 120 may be positionable to overlap the reservoir inlet port 108 independent of an overlap of the fluid outlet port 114. The constrained variable volume 122 may be formed between a first seal 140 around the spool 106, a second seal 142 around the spool 106, an outer surface of the spool body between the first and second seal 140 and 142 and an interior surface of the axial bore 104 between the first and second seal 140 and 142. The first and second seals 140 and 142 are axially moveable relative to each other so as to increase a volume of the constrained variable volume 122 when the first and second seals 140 and 142 are moved away from each other, and decrease the constrained variable volume 122 when the first and second seals 140 and 142 are moved closer together.
The second seal 142 may be disposed on a proximal section 134 of the spool 106 and may move in conjunction with movement of the proximal section 134 of the spool 106. A proximal end of the spool 136 may be coupled to a ball portion 178 of a drive shaft 176 of the drive mechanism 48 of the infusion pump 12. The drive mechanism 48 may include a rack and pinion mechanism 174 actuated by an electric motor 170 through a gear box 172. As such, the second seal 142 may move or translate axially in step with axial translation of the spool 106 and drive shaft 176. The first seal 140, however, may be disposed on a distal section 128 of the spool 106 which may be axially displaceable with respect to the main section 190 of the spool 106. The distal section 128 of the spool 106 may be coupled to the main section of the spool by an axial extension 156 that may be mechanically captured by a cavity 158 in the main section 132 of the spool 106. This configuration may impart a predetermined amount of controlled axial movement between the distal section 128 of the spool and the main section 132 of the spool 106 and may translate the constrained variable volume 122 from the reservoir inlet port 108 to the fluid outlet port 114. This configuration may expand or contract the constrained variable volume 112 of the spool 106 by exerting translational axial force through a boundary section of the constrained variable volume 122.
For some embodiments, a volume of a “bucket” of fluid dispensed by a complete and full dispense cycle of the spool 106 may be approximately equal to the cross-sectional area of the axial bore 104 multiplied by the length of displacement of the captured axial extension of the spool for the distal section 128. The complete bucket of fluid may also be dispensed in smaller sub-volumes in increments as small as a resolution of the drive mechanism 48 allows. For some embodiments, a dispense volume or bucket defined by the constrained variable volume 122 of the delivery mechanism 120 may be divided into about 10 to about 100 sub-volumes to be delivered or dispensed. In some cases, the maximum axial displacement between the distal section 128 and main section of the spool 132 may range from about 0.01 inch to about 0.04 inch; more specifically, from about 0.018 inch to about 0.022 inch.
For some embodiments, the axial bore 104 of the delivery mechanism may have a transverse dimension or diameter ranging from about 0.04 inches to about 0.5 inches; more specifically, from about 0.08 inches to about 0.15 inches. For some embodiments, the spool 106 may have a length ranging from about 10 mm to about 40 mm; more specifically, from about 15 mm to about 20 mm. The spool 106 and housing of the delivery mechanism 48 may be made from any suitable material or materials, including polymers or plastics such as polycarbonate, PEEK, thermoplastics, cyclic olefin copolymer, and the like. In some cases, the seals disposed on the spool may have an outer transverse dimension or diameter that may be slightly larger than that of the spool 106. In some instances, the seals on the spool may have an axial thickness ranging from about 0.01 inches to about 0.03 inches and may be made from materials such as butyl, silicone, polyurethanes or the like having a shore hardness ranging from about 65A to about 75A and, more specifically, about 70A.
In some instances, a second vented volume 154 of the delivery mechanism 120 may be formed by the spool 106 and axial bore 104 of the delivery mechanism 48. The second vented volume 154 may be formed by a third seal 150 disposed around the spool 106 and a fourth seal 152 also disposed around the spool and axially separated from the third seal 150. The axial separation between the third and fourth seals 150 and 152 forming the second vented volume 154 may be greater than the axial separation between the vent inlet port 112 and vent outlet port 116 of the axial bore 104 in some instances. The second vented volume 154 may be formed by an outside surface of the spool 106 between the third and fourth seals 150 and 152 and an inside surface of the axial bore 104 between the third and fourth seals 150 and 152.
The second vented volume 154 may be axially displaceable with the movement of the spool 106 and may also be positionable by such axial displacement in order to simultaneously overlap the second vented volume 154 with the vent inlet port 112 and the vent outlet port 116 of the axial bore 104. Such an overlap of both the vent inlet port 112 and the vent outlet port 116 may put these ports in fluid communication with each other, and may allow an equilibration of pressure between the first vented volume 80 of the infusion cartridge 16 and the environment surrounding the vent outlet port 116. In most cases, the vent outlet port 116 may be in communication with the atmosphere and air may pass from the environment surrounding the vent outlet port 116, through the second vented volume 154 of the axial bore 104, and into the first vented volume 80 to replace the fluid dispensed subsequent to the last vent cycle. When the vent inlet port 112 and vent outlet port 116 do not share a common volume formed by the spool 106 and axial bore 104 of the delivery mechanism 120, they are typically isolated and no venting of the first vented volume 80 may take place.
In operation, the spool 106 defines one or more volumes between the spool 106, the axial bore 104 and the circumferential seals 140, 142, 150 and 152 disposed on the spool of the delivery mechanism 120. The spool 106 is typically translated in a proximal and distal direction in order to move the volumes into and out of communication with the various ports of the axial bore 104. This axial movement in alternating proximal and distal directions of the spool 106 within the axial bore 104 may be used to put the various ports in fluid communication with translatable volumes of the delivery mechanism 120. For reliable operation, it may be desirable in some circumstances for the spool 106 and the circumferential seals 140, 142, 150 and 152 disposed about the spool 106 to move smoothly within the axial bore 104 of the delivery mechanism 120 while maintaining a seal between an outside surface of the spool 106 and an inside surface of the axial bore 104. It may also be desirable for the circumferential seals 140, 142, 150 and 152 disposed on the spool 106 to move axially back and forth within the axial bore 104 while maintaining a seal and with a minimum of friction. Achieving these features of the spool 106 may be facilitated with the use of particular seal configurations or gland configurations used to house the seals of the spool embodiments.
The delivery mechanism 120 may be configured to deliver fluid from the reservoir 68. The delivery mechanism 120 may include a delivery mechanism body 102, or housing, and the axial bore 104 disposed in the delivery mechanism body 102. The axial bore 104 may have a substantially round transverse cross section. The spool 106 may also have a substantially round transverse cross section, and may be slidingly disposed within the axial bore 104. The drive mechanism 48 may include a rack and pinion mechanism 174 actuated by an electric motor 170 through a gear box 172.
With regard to the above detailed description, like reference numerals used therein may refer to like elements that may have the same or similar dimensions, materials, and configurations. While particular forms of embodiments have been illustrated and described, it will be apparent that various modifications can be made without departing from the spirit and scope of the embodiments herein. Accordingly, it is not intended that the invention be limited by the forgoing detailed description.
The entirety of each patent, patent application, publication, and document referenced herein is hereby incorporated by reference. Citation of the above patents, patent applications, publications and documents is not an admission that any of the foregoing is pertinent prior art, nor does it constitute any admission as to the contents or date of these documents.
Modifications may be made to the foregoing embodiments without departing from the basic aspects of the technology. Although the technology may have been described in substantial detail with reference to one or more specific embodiments, changes may be made to the embodiments specifically disclosed in this application, yet these modifications and improvements are within the scope and spirit of the technology. The technology illustratively described herein may suitably be practiced in the absence of any element(s) not specifically disclosed herein. The terms and expressions which have been employed are used as terms of description and not of limitation and use of such terms and expressions do not exclude any equivalents of the features shown and described or portions thereof and various modifications are possible within the scope of the technology claimed. Although the present technology has been specifically disclosed by representative embodiments and optional features, modification and variation of the concepts herein disclosed may be made, and such modifications and variations may be considered within the scope of this technology.
This application is a continuation of application Ser. No. 13/837,661 filed Mar. 15, 2013, which is hereby fully incorporated herein by reference.
| Number | Name | Date | Kind |
|---|---|---|---|
| 4194144 | Reynolds | Mar 1980 | A |
| 5231616 | Oliver et al. | Jul 1993 | A |
| 5243983 | Tarr et al. | Sep 1993 | A |
| 5482446 | Williamson et al. | Jan 1996 | A |
| 5551850 | Williamson et al. | Sep 1996 | A |
| 5676651 | Larson, Jr. et al. | Oct 1997 | A |
| 5681285 | Ford et al. | Oct 1997 | A |
| 6269340 | Ford et al. | Jul 2001 | B1 |
| 6582393 | Sage, Jr. | Jun 2003 | B2 |
| 6673033 | Sciulli et al. | Jan 2004 | B1 |
| 6909840 | Harwig et al. | Jun 2005 | B2 |
| 6981499 | Anderson et al. | Jan 2006 | B2 |
| 6997202 | Olander | Feb 2006 | B2 |
| 7220365 | Qu et al. | May 2007 | B2 |
| 7305975 | Reddy | Dec 2007 | B2 |
| 7442186 | Blomquist | Oct 2008 | B2 |
| 7471994 | Ford et al. | Dec 2008 | B2 |
| 7605710 | Crnkovich et al. | Oct 2009 | B2 |
| 7647237 | Malave et al. | Jan 2010 | B2 |
| 7760601 | Igi | Jul 2010 | B2 |
| 7922458 | Rush et al. | Apr 2011 | B2 |
| 7922462 | Preuthun et al. | Apr 2011 | B2 |
| 7935105 | Miller et al. | May 2011 | B2 |
| 7973667 | Crnkovich et al. | Jul 2011 | B2 |
| 7993108 | Rush et al. | Aug 2011 | B2 |
| 7993300 | Nyholm et al. | Aug 2011 | B2 |
| 8029245 | Rush et al. | Oct 2011 | B2 |
| 8029250 | Rush et al. | Oct 2011 | B2 |
| 8032226 | Miller et al. | Oct 2011 | B2 |
| 8047811 | Rush et al. | Nov 2011 | B2 |
| 8047812 | Rush et al. | Nov 2011 | B2 |
| 8105265 | Demers et al. | Jan 2012 | B2 |
| 8109906 | Smisson, III et al. | Feb 2012 | B2 |
| 8211093 | Miller et al. | Jul 2012 | B2 |
| 8226374 | Peterson et al. | Jul 2012 | B2 |
| 8277416 | Gibbs et al. | Oct 2012 | B2 |
| 8287488 | Miller et al. | Oct 2012 | B2 |
| 8287495 | Michaud et al. | Oct 2012 | B2 |
| 8287514 | Miller et al. | Oct 2012 | B2 |
| 8444592 | Williams et al. | May 2013 | B2 |
| 8573027 | Rosinko et al. | Nov 2013 | B2 |
| 8876769 | Fehr et al. | Oct 2014 | B2 |
| 8986253 | DiPerna | Mar 2015 | B2 |
| 9603995 | Rosinko et al. | Mar 2017 | B2 |
| 20020018720 | Carlisle et al. | Feb 2002 | A1 |
| 20050148938 | Blomquist | Jul 2005 | A1 |
| 20070112301 | Preuthun et al. | May 2007 | A1 |
| 20080249470 | Malave et al. | Oct 2008 | A1 |
| 20090069746 | Miller et al. | Mar 2009 | A1 |
| 20090069749 | Miller et al. | Mar 2009 | A1 |
| 20090069785 | Miller et al. | Mar 2009 | A1 |
| 20090101549 | Kamen et al. | Apr 2009 | A1 |
| 20090107335 | Wilt et al. | Apr 2009 | A1 |
| 20100022937 | Bedingfield et al. | Jan 2010 | A1 |
| 20100164727 | Bazargan | Jul 2010 | A1 |
| 20100192686 | Kamen et al. | Aug 2010 | A1 |
| 20100211003 | Sundar | Aug 2010 | A1 |
| 20110071465 | Wang et al. | Mar 2011 | A1 |
| 20110092894 | Mcgill et al. | Apr 2011 | A1 |
| 20110125085 | Mcgill et al. | May 2011 | A1 |
| 20110163125 | Beavis et al. | Jul 2011 | A1 |
| 20110286008 | Schlaeppi | Nov 2011 | A1 |
| 20120029468 | DiPerna | Feb 2012 | A1 |
| 20120029708 | Miller et al. | Feb 2012 | A1 |
| 20120029941 | Malave et al. | Feb 2012 | A1 |
| 20120078217 | Smith et al. | Mar 2012 | A1 |
| 20120259282 | Alderete, Jr. | Oct 2012 | A1 |
| 20130012917 | Miller et al. | Jan 2013 | A1 |
| 20130053816 | DiPerna et al. | Feb 2013 | A1 |
| 20140039455 | Miller | Feb 2014 | A1 |
| 20140137641 | Brown | May 2014 | A1 |
| 20140276553 | Rosinko et al. | Sep 2014 | A1 |
| 20140276569 | Kruse | Sep 2014 | A1 |
| 20170246380 | Rosinko et al. | Aug 2017 | A1 |
| Number | Date | Country |
|---|---|---|
| WO0130422 | May 2001 | WO |
| WO2010026580 | Mar 2010 | WO |
| WO2011068648 | Jun 2011 | WO |
| WO2012040528 | Mar 2012 | WO |
| Entry |
|---|
| Application and File History for U.S. Appl. No. 13/837,661, filed Mar. 15, 2013, inventor Kruse. |
| Search Report dated Nov. 21, 2016 for European Application No. 14768610.9. |
| PCT Search Report and Written Opinion dated Jul. 1, 2014 for PCT Application No. PCT/US2014/018735 filed Feb. 26, 2014. |
| Number | Date | Country | |
|---|---|---|---|
| 20170246379 A1 | Aug 2017 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 13837661 | Mar 2013 | US |
| Child | 15467500 | US |
